Elwira Przybylik‐Mazurek

Author

Also Known As

E Przybylik-Mazurek, E. Przybylik-Mazurek, Elwira Maria Przybylik-Mazurek, Elwira Przybylik-Mazurek, Elwira Przybylik-Mazurek(†), Elwira Przybylik‐Mazurek, Elwira Przybylik‑Mazurek, Przybylik-Mazurek, Elwira

Publications

443

Citations

H-Index

Concepts

All Affiliations

Jagiellonian University National Centre for Nuclear Research Medical University of Białystok

About

Elwira Przybylik‐Mazurek is an author at Jagiellonian University specializing in medicine, thyroid physiology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	134
2	Public Health	2	2	67
3	Endocrinology	2	2	67
4	Epidemiology	1	1	16
5	Gender Studies	1	1	10

Elwira Przybylik‐Mazurek

Publications

310

Citations

H-Index

Page 1

	Year	Citations
Thyroid Disorders—Assessments of Trace Elements, Clinical, and Laboratory Parameters Elwira Przybylik‐Mazurek, Paweł Zagrodzki, Sylwia Kuźniarz-Rymarz, Biological Trace Element Research Thyroid Disorders—assessmentsIodine Deficiency DisordersThyroid DiseaseDiagnosisThyroid Disorders	2010	57
Iodine prophylaxis—the protective factor against stomach cancer in iodine deficient areas Filip Gołkowski, Z Szybiński, Jadwiga Rachtan, European Journal of Nutrition Stomach CancerGastrointestinal OncologyMedicineIodine Deficiency DisordersPathology	2007	41
A programme of iodine supplementation using only iodised household salt is efficient--the case of Poland Z Szybiński, François Delange, Andrzej Lewiñski, European Journal of Endocrinology	2001	34
Ectopic ACTH syndrome of different origin—Diagnostic approach and clinical outcome. Experience of one Clinical Centre Joanna Ewelina Paleń-Tytko, Elwira Przybylik‐Mazurek, Ewelina Rzepka, PLoS ONE	2020	34
Influence of iodine deficiency and iodine prophylaxis on thyroid cancer histotypes and incidence in endemic goiter area. Bohdan Huszno, Z Szybiński, Elwira Przybylik‐Mazurek, PubMed	2003	27
Glucagon-Like Peptide-1 Receptor Imaging with [Lys <sup> <b>40</b> </sup> (Ahx-HYNIC- <sup> <b>99</b> <b>m</b> </sup> Tc/EDDA)NH <sub> <b>2</b> </sub> ]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer: A Preliminary Report Dorota Pach, Anna Sowa‐Staszczak, Agata Jabrocka‐Hybel, International Journal of Endocrinology	2013	25
Factors connected with the female sex seem to play an important role in differentiated thyroid cancer Elwira Przybylik‐Mazurek, Alicja Hubalewska‐Dydejczyk, Anna Fedorowicz, Gynecological Endocrinology	2011	25
[111In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial Luka Ležaić, Paola Anna Erba, Clemens Decristoforo, European Journal of Nuclear Medicine and Molecular Imaging	2022	21
Effectiveness of the iodine prophylaxis model adopted in Poland Z Szybiński, Monika Buziak‐Bereza, Małgorzata Trofimiuk, Journal of Endocrinological Investigation Drug SafetyEndocrine DisruptorsChemical SafetyIodine Prophylaxis ModelPreventive Medicine	2008	16
Are RECIST criteria sufficient to assess response to therapy in neuroendocrine tumors? Anna Sowa‐Staszczak, Robert Chrzan, Dorota Pach, Clinical Imaging Radiation TherapyMedicineNeuroendocrine DisorderSurgeryNeuroendocrine Tumors	2012	10

Page 1